MEDVi vs Sprout Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MEDVi beats Sprout Health overall, scoring 7.7/10 vs 5.8/10. MEDVi is more affordable at $179/mo vs $199/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Sprout Health for users who want a dedicated care coordinator and locked titra.

A side-by-side look at MEDVi and Sprout Health to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Sprout Health

#49 of 52

5.8/10

Well-established telehealth provider offering both compounded and brand-name GLP-1 medications with solid clinical support.

Visit Sprout Health

Feature	MEDVi	Sprout Health
Our Score	7.7/10	5.8/10
Starting Price	$179/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Users who want a dedicated care coordinator and locked titration pricing, and will judge service quality in month one
Ranking	#20	#49
Get started	Visit MEDVi	Visit Sprout Health

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Sprout Health

Pros

+Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
+Dedicated care coordinator assigned to each patient, not a rotating pool of providers
+Transparent pricing: $250/mo covers medication, shipping, and all consultations
+Operating since 2022 with a consistent track record, no sudden pricing changes or service disruptions

Cons

−$250/mo all-in sits in the upper-mid range, $90 more than Willow for a similar model; the premium pays for the dedicated coordinator and published outcomes
−No insurance accepted, and no superbill provided for FSA/HSA reimbursement

Our Verdict

MEDVi edges out Sprout Health with a score of 7.7/10 vs 5.8/10. If budget is your priority, MEDVi starts at $179/mo compared to Sprout Health's $199/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Sprout Health if you want: users who want a dedicated care coordinator and locked titration pricing, and will judge service quality in month one.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither MEDVi nor Sprout Health feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review